Adoptive transfer of ex vivo expanded CD4+CD25+ Tregs prevents pathology in various mouse models including graft versus host disease (GvHD) [17,18], and GvHD was the first disease to be tried in translation studies in humans. The gene discussed is CD4; the disease is graft versus host disease.